UMR1078

UMR 1078
Genetics, functional genomics
and biotechnology

Publications de l'équipe Levure Modèle de Pathologies Humaines

Publications par année

 

Pour toute information sur les publications, contactez :
helene.simon(at)univ-brest.fr

 

2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004 / 2003 / 2002 / 2001 / 2000 / 1999 / 1997 / 1996


2016

  •  Billant O, Léon A, Le Guellec S, Friocourt G, Blondel M, Voisset C (2016). The dominant-negative interplay between p53, p63 and p73: A family affair. Oncotarget doi: 10.18632/oncotarget.11774.
  • Blondel M, Soubigou F, Evrard J, Nguyen PH, Hasin N, Chédin S, Gillet R, Contesse MA, Friocourt G, Stahl G, Jones GW, Voisset C (2016). Protein Folding Activity of the Ribosome is involved in Yeast Prion Propagation. Sci. Rep. 6, 32117.

HAUT DE PAGE

2015

  • Daskalogianni C, Pyndiah S, Apcher S, Mazars A, Manoury B, Ammari N, Nylander K, Voisset C, Blondel M, Fåhraeus R (2015). Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers. J Pathol 235(2):334-41.
  • Lasserre JP, Dautant A, Aiyar RS, Kucharczyk R, Glatigny A, Tribouillard-Tanvier D, Rytka J, Blondel M, Skoczen N, Reynier P, Pitayu L, Rötig A, Delahodde A, Steinmetz LM, Dujardin G, Procaccio V, di Rago JP (2015). Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies. Dis Model Mech 8(6):509-526.
  • Lista MJ, Voisset C, Contesse MA, Friocourt G, Daskalogianni C, Bihel F, Fåhraeus R, Blondel M (2015).The long-lasting love affair between the budding yeast Saccharomyces cerevisiae and the Epstein-Barr virus. Biotechnol J. 10(11):1670–1681.

HAUT DE PAGE

2014

  • Voisset C, Blondel M. (2014) Chemobiology at happy hour: yeast as a model for pharmacological screening. Med Sci (Paris). 30(12):1161-1168.
  • Aiyar RS, Bohnert M, Duvezin-Caubet S, Voisset C, Gagneur J, Fritsch ES, Couplan E, von der Malsburg K, Funaya C, Soubigou F, Courtin F, Suresh S, Kucharczyk R, Evrard J, Antony C, St Onge RP, Blondel M, di Rago JP, van der Laan M, Steinmetz LM. (2014). Mitochondrial protein sorting as a therapeutic target for ATP synthase disorders. Nat Commun. 5:5585.
  • Montier T, Pichon C, Blondel M, Midoux P. (2014). Editorial: Current status and prospects on nucleic acid transfer. Biotechnol J. 9(11):1363-4.
  • Marcorelles P, Friocourt G, Uguen A, Ledé F, Férec C, Laquerrière A (2014). Cystic Fibrosis Transmembrane Conductance Regulator Protein (CFTR) Expression in the Developing Human Brain: Comparative Immunohistochemical Study between Patients with Normal and Mutated CFTR. J Histochem Cytochem. 62(11):791-801.
  • Nguyen PH, Hammoud H, Halliez S, Pang Y, Evrard J, Schmitt M, Oumata N, Bourguignon JJ, Sanyal S, Beringue V, Blondel M, Bihel F, Voisset C. (2014). Structure-Activity Relationship Study around Guanabenz Identifies Two Derivatives Retaining Antiprion Activity but Having Lost α2-Adrenergic Receptor Agonistic Activity. ACS Chem Neurosci. 5(10):1075-82.
  • Voisset C, Daskalogianni C, Contesse MA, Mazars A, Arbach H, Le Cann M, Soubigou F, Apcher S, Fåhraeus R, Blondel M (2014). A yeast-based assay identifies drugs that interfere with Epstein-Barr virus immune evasion. Dis Model Mech. 7:435-444.
  • Nguyen PH, Oumata N, Soubigou F, Evrard J, Desban N, Lemoine P, Bouaziz S, Galons H, Blondel M and Voisset C (2014). Evaluation of the antiprion activity of 6-aminophenanthridines and related heterocycles. European Journal of Medicinal Chemistry. 82:363-371
  • Voisset C, García-Rodríguez N, Birkmire A, Blondel M, Wellinger RE (2014). Using yeast to model calcium-related diseases: Example of the Hailey-Hailey disease. Biochim Biophys Acta, Molecular Cell Research 1843:2315–2321.
  • Morris MC, Blondel M (2014). Meeting report: 3(rd) Meeting of the Biosensor Workgroup of the GDR2588. Biotechnol J 9(2):178-9.
  • Morris MC, Blondel M (2014). Editorial: Fluorescent biosensors. Biotechnol J. 9(2):171-3.

HAUT DE PAGE

2013

  • Quéméner-Redon S, Bénech C, Audebert-Bellanger S, Friocourt G, Planes M, Parent P, Férec C (2013). A small de novo 16q24.1 duplication in a woman with severe clinical features. Eur J Med Genet 56(4):211-5.
  • Pang Y, Kurella S, Voisset C, Samanta D, Banerjee D, Schabe A, Das Gupta C, Galons H, Blondel M, Sanyal S (2013). The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competition. J Biol Chem 288(26):19081-9.
  • Oumata N, Nguyen PH, Beringue V, Soubigou F, Pang Y, Desban N, Massacrier C, Morel Y, Paturel C, Contesse MA, Bouaziz S, Sanyal S, Galons H, Blondel M, Voisset C (2013). The Toll-Like Receptor Agonist Imiquimod Is Active against Prions. PLoS One 8(8):e72112.

HAUT DE PAGE

2012

  • Blondel M (2012). Flirting with CFTR modifier genes at happy hour. Genome Med 4: 98.
  • Marcorelles P, Gillet D, Friocourt G, Ledé F, Samaison L, Huguen G and Férec C (2012). CFTR protein expression in the male excretory duct system during development. Hum Pathol 43: 390-397.
  • Tribouillard-Tanvier D, Race B, Striebel JF, Carroll JA, Phillips K and Chesebro B (2012). Early cytokine elevation, PrPres deposition, and gliosis in mouse scrapie: no effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35. J Virol 86: 10377-10383.
  • Tribouillard-Tanvier D, Carroll JA, Moore RA, Striebel JF and Chesebro B (2012). Role of cyclophilin A from brains of prion-infected mice in stimulation of cytokine release by microglia and astroglia in vitro. J Biol Chem 287: 4628-4639.

Haut de page

2011

  • Couplan E, Aiyar RS, Kucharczyk R, Kabala A, Ezkurdia N, Gagneur J, St Onge RP, Salin B, Soubigou F, Le Cann M, Steinmetz LM, di Rago JP and Blondel M (2011). A yeast-based assay identifies drugs active against human mitochondrial disorders. Proc Natl Acad Sci USA 108: 11989-11994.
  • Marin M and Blondel M (2011). Editorial: In vivo protein folding--at the crossroad between basic research and biotechnology. Biotechnol J 6: 615-617.
  • Reis SD, Pang Y, Vishnu N, Voisset C, Galons H, Blondel M and Sanyal S (2011). Mode of action of the antiprion drugs 6AP and GA on ribosome assisted protein folding. Biochimie 93: 1047-1054.
  • Voisset C, Saupe SJ and Blondel M (2011). The various facets of the protein-folding activity of the ribosome. Biotechnol J 6: 668-673.
  • Barbezier N, Chartier A, Bidet Y, Buttstedt A, Voisset C, Galons H, Blondel M, Schwarz E and Simonelig M (2011). Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy. EMBO Mol Med 3: 35-49.
  • Quillé ML, Carat S, Quéméner-Redon S, Hirchaud E, Baron D, Benech C, Guihot J, Placet M, Mignen O, Férec C, Houlgatte R and Friocourt G (2011). High-throughput analysis of promoter occupancy reveals new targets for Arx, a gene mutated in mental retardation and interneuronopathies. PLoS One 6: e25181.
  • Friocourt G, Marcorelles P, Saugier-Veber P, Quille ML, Marret S and Laquerrière A (2011). Role of cytoskeletal abnormalities in the neuropathology and pathophysiology of type I lissencephaly. Acta Neuropathol 121: 149-170.
  • Friocourt G and Parnavelas JG (2011). Identification of Arx targets unveils new candidates for controlling cortical interneuron migration and differentiation. Front Cell Neurosci 5: 28.

Haut de page

2010

  • Gug F, Oumata N, Tribouillard-Tanvier D, Voisset C, Desban N, Bach S, Blondel M, and Galons H (2010). Synthesis of conjugates of 6-aminophenanthridine and guanabenz, two structurally unrelated prion inhibitors, for the determination of their cellular targets by affinity chromatography. Bioconjug Chem 21: 279-288.
  • Kucharczyk R, Ezkurdia N, Couplan E, Procaccio V, Ackerman SH, Blondel M and di Rago JP (2010). Consequences of the pathogenic T9176C mutation of human mitochondrial DNA on yeast mitochondrial ATP synthase. Biochim Biophys Acta 1797: 1105-1112.
  • Lecourtois M, Poirier K, Friocourt G, Jaglin X, Goldenberg A, Saugier-Veber P, Chelly J and Laquerrière A. (2010). Human lissencephaly with cerebellar hypoplasia due to mutations in TUBA1A: expansion of the foetal neuropathological phenotype. Acta Neuropathol 119: 779-789.
  • Marcorelles P, Laquerrière A, Adde-Michel C, Marret S, Saugier-Veber P, Beldjord C and Friocourt G (2010). Evidence for tangential migration disturbances in human lissencephaly resulting from a defect in LIS1, DCX and ARX genes. Acta Neuropathol 120: 503-515.
  • Friocourt G and Parnavelas JG. (2010). Mutations in ARX result in several defects involving GABAergic neurons. Front Cell Neurosci 4: 4.

Haut de page

2009

  • Couplan E, Le Cann M, Le Foll C, Corporeau C, Blondel M and Delarue J (2009). Polyunsaturated fatty acids inhibit PI3K activity in a yeast-based model system. Biotechnol J 4: 1190-1197.
  • Kucharczyk R, Zick M, Bietenhader M, Rak M, Couplan E, Blondel M, Caubet SD, and di Rago JP (2009). Mitochondrial ATP synthase disorders: molecular mechanisms and the quest for curative therapeutic approaches. Biochim Biophys Acta 1793: 186-199.
  • Sasvari Z., Bach S., Blondel M and Nagy PD (2009). Inhibition of RNA recruitment and replication of an RNA virus by acridine derivatives with known anti-prion activities. PLoS One 4: e7376.
  • Voisset C, Saupe S and Blondel M (2009). Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models. Infectious Diseases, Drug Targets 9: 31-39.
  • Tribouillard-Tanvier D, Striebel JF, Peterson KE and Chesebro B (2009). Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels. J Virol 83: 11244-11253.

Haut de page

2008

  • Norez C, Vandebrouck C, Antigny F, Dannhoffer L, Blondel M and Becq F (2008). Guanabenz, an alpha2-selective adrenergic agonist, activates Ca2 -dependent chloride currents in cystic fibrosis human airway epithelial cells. Eur J Pharmacol 592: 33-40.
  • Tribouillard-Tanvier D, Beringue V, Desban N, Gug F, Bach S, Voisset C, Galons H, Laude H, Vilette D and Blondel M. (2008). Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions. PLoS One 3: e1981.
  • Tribouillard-Tanvier D, Dos Reis S, Gug F, Voisset C, Beringue V, Sabate R, Kikovska E, Talarek N, Bach S, Huang C, Desban N, Saupe SJ, Supattapone S, Thuret JY, Chedin S, Vilette D, Galons H, Sanyal S and Blondel M (2008). Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs. PLoS One 3: e2174.
  • Voisset C, Thuret JY, Tribouillard-Tanvier D, Saupe SJ and Blondel M (2008). Tools for the study of ribosome-borne protein folding activity. Biotechnol J 3: 1033-1040.
  • Voisset C, Lavie M, Helle F, Op De Beeck A, Bilheu A, Bertrand-Michel J, Tercé F, Cocquerel L, Wychowski C, Vu-Dac N and Dubuisson J (2008). Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. Cell Microbiol 10: 606-617.
  • Voisset C, Weiss RA and Griffiths DJ (2008). Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev 72: 157-196.
  • Friocourt G, Kanatani S, Tabata H, Yozu M, Takahashi T, Antypa M, Raguénès O, Chelly J, Férec C, Nakajima K, Parnavelas JG (2008). Cell-autonomous roles of ARX in cell proliferation and neuronal migration during corticogenesis. J Neurosci 28: 5794-5805.

Haut de page

2007

  • Blondel M and Meijer L (2007). Editorial: role of cyclin-dependent kinase-5 (Cdk5) in the central nervous system. Biotechnol J 2: 914-915.
  • Guiffant D, Tribouillard D, Gug F, Galons H, Meijer L, Blondel M and Bach S (2007). Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography. Biotechnol J 2: 68-75.
  • Tribouillard D, Gug F, Galons H, Bach S, Saupe SJ and Blondel M (2007). Antiprion drugs as chemical tools to uncover mechanisms of prion propagation. Prion 1: 48-52.
  • Helle F, Goffard A, Morel V, Duverlie G, McKeating J, Keck ZY, Foung S, Penin F, Dubuisson J and Voisset C (2007). The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein. J Virol 81: 8101-8111.
  • Johansson DX, Voisset C, Tarr AW, Aung M, Ball JK, Dubuisson J and Persson MA (2007). Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proc Natl Acad Sci USA 104: 16269-16274.
  • Friocourt G, Liu J, Antypa M, Rakic S, Walsh CA and Parnavelas JG (2007). Both Doublecortin and Doublecortin-like kinase play a role in cortical interneuron migration. J Neurosci 27, 3875-3883.
  • Trouvé P, Le Drévo MA, Kerbiriou M, Friocourt G, Fichou Y, Gillet D, Férec C (2007). Annexin V interacts with cystic fibrosis transmembrane conductance regulator. Biochim Biophys Acta 1772: 1121-1133.
  • Friocourt G (2007). From genes to human diseases in cortical development. Bioessays 29: 706-709.

Haut de page

2006

  • Bach S, Tribouillard D, Talarek N, Desban N, Gug F, Galons H and Blondel M (2006). A yeast-based assay to isolate drugs active against mammalian prions. Methods 39: 72-77.
  • Tribouillard D, Bach S, Gug F, Desban N, Beringue V, Andrieu T, Dormont D, Galons H, Laude H, Vilette D and Blondel M (2006). Using budding yeast to screen for anti-prion drugs. Biotechnol J 1: 58-67.
  • Thuret JY and Blondel M (2006). Ready for an orange revolution in biotechnology? Biotechnol J 1: 237-238.
  • Bach S, Blondel M and Meijer L (2006). Evaluation of CDK inhibitors selectivity: from affinity chromatography to yeast genetics. Chapter in Enzyme Inhibitors Volume 2 “Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents” Edited by Yue E.W. and Smith P.J. CRC press, 103-119.
  • Cocquerel L, Voisset C and Dubuisson J (2006). Hepatitis C virus entry: potential receptors and their biological functions. J Gen Virol 87: 1075-1084.
  • Dreux M, Pietschmann T, Granier C, Voisset C, Ricard-Blum S, Mangeot PE, Keck Z, Foung S, Vu-Dac N, Dubuisson J, Bartenschlager R, Lavillette D and Cosset FL (2006). High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. J Biol Chem 281: 18285-18295.
  • Helle F, Wychowski C, Vu-Dac N, Gustafson KR, Voisset C and Dubuisson J (2006). Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. J Biol Chem 281: 25177-25183.
  • Lavie M, Voisset C, Vu-Dac N, Zurawski V, Duverlie G, Wychowski C and Dubuisson J (2006). Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system. Hepatology 44: 1626-1634.
  • Rouille Y, Helle F, Delgrange D, Roingeard P, Voisset C, Blanchard E, Belouzard S, McKeating J, Patel AH, Maertens G, Wakita T, Wychowski C and Dubuisson J (2006). Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol 80: 2832-2841.
  • Voisset C, Op De Beeck A, Horellou P, Dreux M, Gustot T., Duverlie, G., Cosset, F.L., Vu-Dac, N., and Dubuisson, J. (2006). High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry. J Gen Virol 87, 2577-2581.
  • Friocourt G, Poirier K, Rakic S, Parnavelas JG and Chelly J. (2006). The role of ARX in brain development. Eur. J. Neurosci. 23, 869-876.

Haut de page

2005

  • Gug F, Blondel M, Desban N, Bouaziz S, Vierfond JM and Galons H (2005). An expeditious synthesis of 6-aminophenanthridines. Tetrahedron Letters 46: 3725-3727.
  • Blondel M, Bach S, Bamps S, Dobbelaere J, Wiget P, Longaretti C, Barral Y, Meijer L and Peter M (2005). Degradation of Hof1 by SCFGrr1 is important for actomyosin contraction during cytokinesis in yeast. Embo J 24: 1440-1452.
  • Voisset C, Callens N, Blanchard E, Op De Beeck A, Dubuisson J, Vu-Dac N. (2005). High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 280: 7793-7799
  • Lavillette D, Tarr AW, Voisset C, Donot P, Bartosch B, Bain C, Patel AH, Dubuisson J, Ball JK, Cosset FL. (2005). Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41: 265-274.
  • Friocourt G, Kappeler C, Saillour Y, Fauchereau F, Rodriguez MS, Bahi N, Vinet MC, Chafey P, Poirier K, Taya, S, Wood, SA, Dargemont C, Francis F and Chelly J. (2005) Doublecortin interacts with the ubiquitin protease DFFRX, which associates with microtubules in neuronal processes. Mol Cell Neurosci 28: 153-164.

Haut de page

2004

  • Adolph S, Bach S, Blondel M, Cueff A, Moreau M, Pohnert G, Poulet SA, Wichard T, Zuccaro A (2004). Cytotoxicity of diatom-derived oxylipins in organisms belonging to different phyla. J Exp Biol 207: 2935-2946.
  • Knockaert M, Blondel M, Bach S, Leost M, Elbi C, Hager GL, Nagy SR, Han D, Denison M, Ffrench M, Ryan XP, Magiatis P, Polychronopoulos P, Greengard P, Skaltsounis L and Meijer L (2004). Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the anti-proliferative effects of indirubins. Oncogene 23: 4400-4412.
  • Gug F, Bach S, Blondel M, Vierfond JM, Martin AS and Galons H (2004) A single step synthesis of 6-aminophenanthridines from anilines and 2-chlorobenzonitriles. Tetrahedron 60: 4705-4708.
  • Voisset C and Dubuisson J. (2004). Functional hepatitis C virus envelope glycoproteins. Biol Cell 96: 413-20.
  • Op De Beeck A, Voisset C, Bartosch B, Ciczora Y, Cocquerel L, Keck Z, Foung S, Cosset FL and Dubuisson J. (2004). Characterization of Functional Hepatitis C Virus Envelope Glycoproteins. J Virol 78: 2994-3002.
  • Poirier K, Van Esch H, Friocourt G, Saillour Y, Bahi N, Backer S, Souil E, Castelnau-Ptakhine L, Beldjord C, Francis F, Bienvenu T and Chelly J (2004). Neuroanatomical distribution of ARX in brain and its localisation in GABAergic neurons. Mol Brain Res 122: 35-46.

Haut de page

2003

  • Gstaiger M, Luke B, Hess D, Oakeley EJ, Wirbelauer C, Blondel M, Vigneron M, Peter M and Krek W (2003). Control of Nutrient-Sensitive Transcription Programs by the Unconventional Prefoldin URI. Science 302: 1208-1212.
  • Bach S, Talarek N, Andrieu T, Vierfond JM, Mettey Y, Galons H, Dormont D, Meijer L, Cullin C and Blondel M (2003). Isolation of drugs active against mammalian prions using a yeast-based screening assay . Nat Biotech 21: 1075-1081.
  • Voisset C., Myers RE, Carne A, Kellam P and Griffiths DJ (2003). Rabbit endogenous retrovirus-H encodes a functional protease. J Gen Virol 84: 215-225.
  • Bahi N, Friocourt G, Carrié A, Graham ME, Weiss JL, Chafey P, Fauchereau F, Burgoyne RD and Chelly J (2003). IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis. Hum Mol Genet 12: 1415-25.
  • Friocourt G, Koulakoff A, Chafey P, Boucher D, Fauchereau F, Chelly J and Francis F (2003). Doublecortin functions at the extremities of growing neuronal processes. Cereb Cortex 13: 620-626.

Haut de page

2002

  • Griffiths DJ, Voisset C, Venables PJW and Weiss RA (2002). A novel endogenous retrovirus in rabbits previously reported as human retrovirus 5. J Virol 76: 7094-7102.
  • Bienvenu T, Poirier K, Friocourt G, Bahi N, Beaumont D, Fauchereau F, Ben Jeema L, Zemni R, Vinet MC, Francis F, Couvert P, Gomot M, Moraine C, van Bokhoven H, Kalscheuer V, Frints S, Gecz J, Ohzaki K, Chaabouni H, Fryns JP, Des Portes V, Beldjord C, and Chelly J (2002). ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum Mol Genet 11: 981-991.
  • Benchoua A, Couriaud C, Guegan C, Tartier L, Couvert P, Friocourt G, Chelly J, Menissier-De Murcia J and Onteniente B. (2002). Active caspase-8 translocates into the nucleus of apoptotic cells to inactivate poly(ADP-ribose) polymerase-2. J Biol Chem 277: 34217-22.

Haut de page

2001

  • Voisset C, Tönjes RR, Breyton P, Mandrand B and Paranhos-Baccalà G (2001). Specific detection of RT activity in culture supernatants of retrovirus-producing cells using synthetic DNA as competitor in polymerase enhanced reverse transcriptase assay. J Virol Methods 94: 187-193.
  • Bordet T, Castelnau-Ptakhine L, Fauchereau F, Friocourt G, Kahn A and Haase G. (2001). Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin C fragment. Mol Cell Neurosci 17: 842-854.
  • Friocourt G, Chafey P, Billuart P, Koulakoff A, Vinet MC, Schaar BT, McConnell SK, Francis F and Chelly J. (2001). Doublecortin interacts with µ Subunits of clathrin adaptor complexes in the developing nervous system. Mol Cell Neurosci 18: 307-319.

Haut de page

2000

  • Blondel M, Galan JM, Chi Y, Lafourcade C, Longaretti C, Deshaies RJ and Peter M (2000). Nuclear-specific degradation of Far1 is controlled by the localization of the F-box protein Cdc4. Embo J 19: 6085-6097.
  • Wirbelauer C, Sutterluty H, Blondel M, Gstaiger M, Peter M, Reymond F and Krek W (2000). The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts. Embo J 19: 5362-5375.
  • Blondel M, Galan JM and Peter M. (2000). Isolation and characterization of HRT1 using a genetic screen for mutants unable to degrade Gic2p in Saccharomyces cerevisiae. Genetics 155: 1033-1044.
  • Bouquin N, Barral Y, Courbeyrette R, Blondel M, Snyder M and Mann C (2000). Regulation of cytokinesis by the Elm1 protein kinase in Saccharomyces cerevisiae. J Cell Sci 113: 1435-1445.
  • Voisset C, Bouton O, Bedin F, Duret L, Mandrand B, Mallet F, Paranhos-Baccalà G (2000). Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family.AIDS Res Hum Retroviruses 16: 731-740.
  • Voisset C, Mandrand B and Paranhos-Baccalà G (2000). RNA amplification technique, NASBA, also amplifies homologous plasmid DNA in non-denaturing conditions. Biotechniques 29: 236-238.
  • Zemni R, Bienvenu T, Vinet MC, Sefiani A, Carrie A, Billuart P, McDonell N, Couvert P, Francis F, Chafey P, Fauchereau F, Friocourt G, Des Portes V, Cardona A, Frints S, Meindl A, Brandau O, Ronce N, Moraine C, van Bokhoven H, Ropers HH, Sudbrak R, Kahn A, Fryns JP, Beldjord C and Chelly J. (2000). A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet 24: 167-170.

Haut de page

1999

  • Blondel M, Alepuz PM, Huang LS, Shaham S, Ammerer G and Peter M (1999). Nuclear export of Far1p in response to pheromones requires the export receptor Msn5p/Ste21p. Genes Dev 13: 2284-2300.
  • Voisset C, Blancher A, Perron H, Mandrand B, Mallet F and Paranhos-Baccalà G (1999). Phylogeny of a novel family of human endogenous retrovirus sequences, HERV-W, in humans and other primates. AIDS Res Hum Retroviruses 15: 1529-1533.
  • Elaissari A, Holt L, Meunier F, Voisset C, Pichot C, Mandrand B and Mabilat C (1999). Hydrophilic and cationic latex particles for the specific extraction of nucleic acids. J Biomater Sci Polym Ed 10: 403-420.
  • Francis F, Koulakoff A, Boucher D, Chafey P, Schaar B, Vinet MC, Friocourt G, McDonnell N, Reiner O, Kahn A, McConnell SK, Berwald-Netter Y, Denoulet P and Chelly J. (1999). Doublecortin is a developmentally regulated microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 23: 247-256.

HAUT DE PAGE

1997

  • Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccalà G, Komurian-Pradel F, Mallet F, Tuke P.W., Voisset C., Blond J.L., Lalande B., Seigneurin J.M., Mandrand B (1997). Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci USA 94: 7583-7588.

HAUT DE PAGE

1996

  • Blondel M and Mann C (1996). G2 cyclins are required for the degradation of G1 cyclins in yeast. Nature 384: 279-282.

HAUT DE PAGE